![](/img/cover-not-exists.png)
D49Phase ii study of mytomicin-c plus uft/lv in patients with metastatic colorectal cancer refractory to standard chemotherapy. subgroup analysis of predictive variables in discriminating early progressors
Sonetto, C., Baratelli, C., Brizzi, M.P., Di Maio, M., Scagliotti, G.V., Tampellini, M.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw335.49
Date:
September, 2016
File:
PDF, 59 KB
2016